Sotorasib, sold under the brand names Lumakras and Lumykras, is an anti-cancer medication used to treat non-small-cell lung cancer. It targets a specific mutation, G12C, in the protein K-Ras encoded by gene KRAS which is responsible for various forms of cancer.Sotorasib is an inhibitor of the RAS GTPase family
| CAS No. | 2296144-83-1 |
| Molecular Weight (g/mol) | 560.6060 |
| Molecular Formula | C30H30F2N6O3 |